TickerGuard
Buy Day today: Good (66) Broad market participation · no major macro event

Precigen Inc (PGEN)

Healthcare Biotechnology
6.50 $
-1.2% vs. previous close
Closing price · As of: 4. Aug 2026

Precigen Inc (PGEN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 139 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Balance Sheet PGEN
Tick rows to compare them in a chart (up to 4) Q2 16 Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26
1,031 1,006 949 916 934 898 847 896 825 980 716 710 655 605 456 405 362 336 315 407 403 377 360 336 321 259 216 242 208 191 151 135 73 83 145 129 102 171 157 139
346 316 315 282 234 180 154 188 148 310 285 232 183 157 235 189 173 151 149 144 157 153 157 155 165 163 118 138 106 93 69 50 24 35 102 85 63 130 115 102
155 70 63 70 64 64 68 120 78 82 103 107 58 44 66 38 47 28 52 27 36 42 36 40 44 92 4.9 9.7 17 10 7.6 17 9.3 25 30 6.1 14 14 30 7.5
271 237 237 205 157 109 80 124 81 247 223 182 126 106 75 149 133 113 100 106 115 114 109 112 115 154 56 104 88 74 63 45 20 29 98 80 60 121 98 56
44 42 42 43 44 38 40 31 34 30 28 25 34 25 26 20 24 19 20 21 27 21 2.0 25 1.9 2.5 14 16 14 14 1.6 1.2 1.0 0.7 1.2 1.1 0.6 1.1 4.4 27
24 22 21 19 19 18 20 20 20 18 21 20 18 17 16 15 13 10 11 11 11 9.9 0.3 13 0.2 0.2 0.3 14 – – 0.0 0.0 – – 0.0 – – 3.1 9.6 15
47 – 65 68 93 103 113 119 119 123 129 136 120 123 61 60 47 64 35 34 45 45 45 34 17 7.6 7.3 6.9 6.6 – – – – – – – – – – –
161 160 157 158 165 167 153 155 152 151 150 151 150 148 64 64 54 54 54 54 54 54 38 54 37 37 37 37 37 37 27 27 25 25 19 19 15 15 15 15
244 239 226 223 240 241 233 232 219 213 129 126 113 107 68 65 65 65 65 61 60 57 52 51 46 42 44 44 43 40 41 39 5.1 4.8 4.5 4.1 3.8 3.5 3.2 2.9
403 397 380 366 362 345 300 324 258 425 337 375 376 376 384 317 312 278 247 232 243 246 253 262 266 117 90 57 41 43 33 38 30 28 107 143 139 129 136 118
95 101 95 91 96 88 80 87 83 92 62 59 52 82 123 71 64 31 42 25 29 29 35 26 30 105 79 47 31 33 23 29 23 21 22 24 23 32 37 21
1.0 1.0 1.2 0.8 0.7 0.7 0.7 0.8 1.1 0.7 2.5 5.6 5.7 38 36 37 41 9.6 3.0 5.7 2.3 4.3 1.4 3.5 1.0 83 44 15 1.4 1.2 1.2 1.3 1.3 1.0 1.0 0.9 0.9 1.1 1.1 1.1
8.2 7.9 8.5 8.0 8.2 7.9 8.7 7.8 8.4 8.5 12 13 8.6 7.4 5.5 4.9 3.7 4.2 4.6 4.3 4.9 3.6 3.1 4.4 2.7 4.2 4.1 3.8 2.5 2.4 1.7 4.7 4.8 4.3 3.5 3.1 3.9 6.3 12 2.6
7.5 – 7.6 7.6 7.7 7.7 7.5 7.4 7.3 183 211 214 212 184 186 189 191 194 172 174 177 180 183 201 199 – – – – – – – – – – – – 93 93 94
619 600 560 529 551 534 534 553 550 539 363 313 279 228 72 87 50 59 67 175 159 131 107 74 56 143 126 184 166 148 118 97 43 55 39 -14 -37 42 21 20
-656 -685 -729 -762 -781 -821 -848 -930 -933 -990 -1,331 -1,391 -1,430 -1,484 -1,653 -1,709 -1,752 -1,782 -1,823 -1,841 -1,861 -1,891 -1,916 -1,916 -1,934 -1,846 -1,869 -1,891 -1,912 -1,931 -1,964 -1,988 -2,047 -2,071 -2,091 -2,145 -2,172 -2,318 -2,341 -2,349
118 118 119 119 120 121 121 128 129 130 132 153 154 155 155 160 164 166 178 193 199 199 199 200 200 201 208 230 248 249 249 249 252 276 293 294 296 296 313 313

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: August 4, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?